Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Marie-Odile KrebsOussama KebirTherese M JayPublished in: European journal of pain (London, England) (2019)
The assessment of benefice-risk balance of medical use of cannabis and cannabinoids needs to carefully explore populations that could be more at-risk of psychiatric and cognitive complications.